BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
303 hedge funds and large institutions have $9B invested in bluebird bio in 2018 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 93 increasing their positions, 113 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
+7
Holders Change %
+2.36%
% of All Funds
6.95%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
56
Increased
93
Reduced
113
Closed
44
Calls
$185M
Puts
$168M
Net Calls
+$17.5M
Net Calls Change
-$69.5M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$174M |
| 2 |
Goldman Sachs
New York
|
+$64.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$56.9M |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$49.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.7M |
